These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 1541665)
1. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665 [TBL] [Abstract][Full Text] [Related]
2. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors]. Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women. Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension. Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862 [TBL] [Abstract][Full Text] [Related]
5. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. Seed M; Hoppichler F; Reaveley D; McCarthy S; Thompson GR; Boerwinkle E; Utermann G N Engl J Med; 1990 May; 322(21):1494-9. PubMed ID: 2139920 [TBL] [Abstract][Full Text] [Related]
6. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023 [TBL] [Abstract][Full Text] [Related]
7. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239 [TBL] [Abstract][Full Text] [Related]
8. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus. Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002 [TBL] [Abstract][Full Text] [Related]
10. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy. Cubrilo-Turek M; Sertić J; Duraković Z Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019 [TBL] [Abstract][Full Text] [Related]
13. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease. Onat A Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827 [TBL] [Abstract][Full Text] [Related]
14. Concentrations of the atherogenic Lp(a) are elevated in FH. Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014 [TBL] [Abstract][Full Text] [Related]
15. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity. Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466 [TBL] [Abstract][Full Text] [Related]
16. [Apolipoprotein (a) polymorphism in relation to coronary heart disease in Chinese Han nationality]. Qin S; Wang S; Li C Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):588-91, 637-8. PubMed ID: 8697071 [TBL] [Abstract][Full Text] [Related]
17. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Rasouli M; Kiasari AM Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) status in coronary heart disease. Khan MA; Baseer A J Pak Med Assoc; 2000 Feb; 50(2):47-50. PubMed ID: 10769521 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. Hoogeveen RC; Gambhir JK; Gambhir DS; Kimball KT; Ghazzaly K; Gaubatz JW; Vaduganathan M; Rao RS; Koschinsky M; Morrisett JD J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835 [TBL] [Abstract][Full Text] [Related]
20. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Sandholzer C; Saha N; Kark JD; Rees A; Jaross W; Dieplinger H; Hoppichler F; Boerwinkle E; Utermann G Arterioscler Thromb; 1992 Oct; 12(10):1214-26. PubMed ID: 1390593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]